CS logo
small CS logo
University College London Hospitals NHS Foundation Trust; NIHR UCLH Clinical Research Facility

London, United Kingdom
Medical clinic in London, England
170 Tottenham Court Rd, London W1T 7HA

About University College London Hospitals NHS Foundation Trust; NIHR UCLH Clinical Research Facility


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at University College London Hospitals NHS Foundation Trust; NIHR UCLH Clinical Research Facility


During the past decade, University College London Hospitals NHS Foundation Trust; NIHR UCLH Clinical Research Facility conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at University College London Hospitals NHS Foundation Trust; NIHR UCLH Clinical Research Facility


According to Clinical.Site data, the most researched conditions in "University College London Hospitals NHS Foundation Trust; NIHR UCLH Clinical Research Facility" are "Multiple Myeloma" (2 trials), "Adenocarcinoma" (1 trials), "Adenocarcinoma, Papillary" (1 trials), "Advanced Solid Tumors" (1 trials) and "B-Cell Lymphoma" (1 trials). Many other conditions were trialed in "University College London Hospitals NHS Foundation Trust; NIHR UCLH Clinical Research Facility" in a lesser frequency.

Clinical Trials Intervention Types at University College London Hospitals NHS Foundation Trust; NIHR UCLH Clinical Research Facility


Most popular intervention types in "University College London Hospitals NHS Foundation Trust; NIHR UCLH Clinical Research Facility" are "Drug" (8 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Glofitamab" (3 trials), "Tocilizumab" (3 trials), "Atezolizumab" (2 trials), "Obinutuzumab" (2 trials) and "89Zr-Df-IAB22M2C" (1 trials). Other intervention names were less common.

Clinical Trials Genders at University College London Hospitals NHS Foundation Trust; NIHR UCLH Clinical Research Facility


The vast majority of trials in "University College London Hospitals NHS Foundation Trust; NIHR UCLH Clinical Research Facility" are 8 trials for "All" genders.

Clinical Trials Status at University College London Hospitals NHS Foundation Trust; NIHR UCLH Clinical Research Facility


Currently, there are NaN active trials in "University College London Hospitals NHS Foundation Trust; NIHR UCLH Clinical Research Facility". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in University College London Hospitals NHS Foundation Trust; NIHR UCLH Clinical Research Facility, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in University College London Hospitals NHS Foundation Trust; NIHR UCLH Clinical Research Facility, 7 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".